First Results from New High Magnetic Field Measurements with the MediTPC Prototype

In the ILD concept, a TPC is foreseen as the main tracking device. The MediTPC prototype has been developed at DESY to study the properties of Gas Electron Multipliers (GEMs) and to perform resolution studies. Studies of the influence of oxygen contaminations on the electron signal are presented here. Further, resolution results with new pad planes with 1.27x7.0 sqmm pad pitch and in high magnetic fields are shown.Comment: 3 pages, 4 figures, LCWS08 conference proceeding

A Lightweight Field Cage for a Large TPC Prototype for the ILC

We have developed and constructed the field cage of a prototype Time Projection Chamber for research and development studies for a detector at the International Linear Collider. This prototype has an inner diameter of 72 cm and a length of 61 cm. The design of the field cage wall was optimized for a low material budget of 1.21 % of a radiation length and a drift field homogeneity of Delta(E)/(E) less or equal 10^-4. Since November 2008 the prototype has been part of a comprehensive test beam setup at DESY and used as a test chamber for the development of Micro Pattern Gas Detector based readout devices.Comment: 16 pages, 13 figures, 3 table

Beam Test with a GridGEM TPC Prototype Module

The International Large Detector (ILD) --a detector concept for the International Linear Collider (ILC)-- foresees a Time Projection Chamber (TPC) as its main tracking detector. Currently, the R&D efforts for such a TPC focus on studies using a large prototype that can accommodate up to seven read-out modules which are comparable to the ones that would be used in the final ILD TPC. The DESY TPC group has developed such a module using GEMs for the gas amplification, which are mounted on thin ceramic frames. The module design and first results of a test beam campaign are presented.Comment: 6 pages, 11 figures, prepared for LCWS 2011 proceeding

Threshold analyses and Lorentz violation

In the context of threshold investigations of Lorentz violation, we discuss the fundamental principle of coordinate invariance, the role of an effective dynamical framework, and the conditions of positivity and causality. Our analysis excludes a variety of previously considered Lorentz-breaking parameters and opens an avenue for viable dispersion-relation investigations of Lorentz violation.Comment: 9 page

Summary and Conclusions of the First DESY Test Beam User Workshop

On October 5/6, 2017, DESY hosted the first DESY Test Beam User Workshop [1] which took place in Hamburg. Fifty participants from different user communities, ranging from LHC (ALICE, ATLAS, CMS, LHCb) to FAIR (CBM, PANDA), DUNE, Belle-II, future linear colliders (ILC, CLIC) and generic detector R&D presented their experiences with the DESY II Test Beam Facility, their concrete plans for the upcoming years and a first estimate of their needs for beam time in the long-term future beyond 2025. A special focus was also on additional improvements to the facility beyond its current capabilities

A Time Projection Chamber with GEM-Based Readout

For the International Large Detector concept at the planned International Linear Collider, the use of time projection chambers (TPC) with micro-pattern gas detector readout as the main tracking detector is investigated. In this paper, results from a prototype TPC, placed in a 1 T solenoidal field and read out with three independent GEM-based readout modules, are reported. The TPC was exposed to a 6 GeV electron beam at the DESY II synchrotron. The efficiency for reconstructing hits, the measurement of the drift velocity, the space point resolution and the control of field inhomogeneities are presented.Comment: 22 pages, 19 figure

The Changing Landscape for Stroke\ua0Prevention in AF: Findings From the GLORIA-AF Registry Phase 2

Background GLORIA-AF (Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation) is a prospective, global registry program describing antithrombotic treatment patterns in patients with newly diagnosed nonvalvular atrial fibrillation at risk of stroke. Phase 2 began when dabigatran, the first non\u2013vitamin K antagonist oral anticoagulant (NOAC), became available. Objectives This study sought to describe phase 2 baseline data and compare these with the pre-NOAC era collected during phase 1. Methods During phase 2, 15,641 consenting patients were enrolled (November 2011 to December 2014); 15,092 were eligible. This pre-specified cross-sectional analysis describes eligible patients\u2019 baseline characteristics. Atrial fibrillation disease characteristics, medical outcomes, and concomitant diseases and medications were collected. Data were analyzed using descriptive statistics. Results Of the total patients, 45.5% were female; median age was 71 (interquartile range: 64, 78) years. Patients were from Europe (47.1%), North America (22.5%), Asia (20.3%), Latin America (6.0%), and the Middle East/Africa (4.0%). Most had high stroke risk (CHA2DS2-VASc [Congestive heart failure, Hypertension, Age  6575 years, Diabetes mellitus, previous Stroke, Vascular disease, Age 65 to 74 years, Sex category] score  652; 86.1%); 13.9% had moderate risk (CHA2DS2-VASc = 1). Overall, 79.9% received oral anticoagulants, of whom 47.6% received NOAC and 32.3% vitamin K antagonists (VKA); 12.1% received antiplatelet agents; 7.8% received no antithrombotic treatment. For comparison, the proportion of phase 1 patients (of N = 1,063 all eligible) prescribed VKA was 32.8%, acetylsalicylic acid 41.7%, and no therapy 20.2%. In Europe in phase 2, treatment with NOAC was more common than VKA (52.3% and 37.8%, respectively); 6.0% of patients received antiplatelet treatment; and 3.8% received no antithrombotic treatment. In North America, 52.1%, 26.2%, and 14.0% of patients received NOAC, VKA, and antiplatelet drugs, respectively; 7.5% received no antithrombotic treatment. NOAC use was less common in Asia (27.7%), where 27.5% of patients received VKA, 25.0% antiplatelet drugs, and 19.8% no antithrombotic treatment. Conclusions The baseline data from GLORIA-AF phase 2 demonstrate that in newly diagnosed nonvalvular atrial fibrillation patients, NOAC have been highly adopted into practice, becoming more frequently prescribed than VKA in Europe and North America. Worldwide, however, a large proportion of patients remain undertreated, particularly in Asia and North America. (Global Registry on Long-Term Oral Antithrombotic Treatment in Patients With Atrial Fibrillation [GLORIA-AF]; NCT01468701

Research and Design of a Routing Protocol in Large-Scale Wireless Sensor Networks

无线传感器网络，作为全球未来十大技术之一，集成了传感器技术、嵌入式计算技术、分布式信息处理和自组织网技术，可实时感知、采集、处理、传输网络分布区域内的各种信息数据，在军事国防、生物医疗、环境监测、抢险救灾、防恐反恐、危险区域远程控制等领域具有十分广阔的应用前景。 本文研究分析了无线传感器网络的已有路由协议，并针对大规模的无线传感器网络设计了一种树状路由协议，它根据节点地址信息来形成路由，从而简化了复杂繁冗的路由表查找和维护，节省了不必要的开销，提高了路由效率，实现了快速有效的数据传输。 为支持此路由协议本文提出了一种自适应动态地址分配算——ADAR（AdaptiveDynamicAddre...As one of the ten high technologies in the future, wireless sensor network, which is the integration of micro-sensors, embedded computing, modern network and Ad Hoc technologies, can apperceive, collect, process and transmit various information data within the region. It can be used in military defense, biomedical, environmental monitoring, disaster relief, counter-terrorism, remote control of haz...学位：工学硕士院系专业：信息科学与技术学院通信工程系_通信与信息系统学号：2332007115216